Streetbeat News

Stock Prices

AMGN

A significant bearish stance has been taken on Amgen (NASDAQ:AMGN) by a large investor, as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 31% bullish and 68% bearish. The whales have been targeting a price range from $210.0 to $280.0 for Amgen over the last 3 months. The price of AMGN is up 2.45% at $270.79. Truist Securities downgraded its action to Hold with a price target of $260, Argus Research maintained their Buy rating with a price target of $280, and HSBC downgraded its action to Buy with a price target of $320.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 4:16 pm

LULU

Investor Business Daily SwingTrader has reportedly purchased stock in Lululemon Athletica.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 4:14 pm

GPRE

Green Plains Partners has recently combined with an activist-targeted ethanol fuel company, making the latter more attractive to buyers and facilitating asset divestment. This has resulted in a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 4:13 pm

SPY

The U.S. government is facing a potential shutdown due to budget negotiations deadlock in Congress. The White House warns of potential damage to the economy and national security. Goldman Sachs predicts a temporary shutdown is increasingly likely, which could reduce quarterly annualized growth by around 0.2 percentage points for each week it persists. Historically, financial markets have not shown significant reactions during government shutdowns, with the S&P 500 recording above-average returns in the year following a shutdown.

Portfolio Pulse from Piero Cingari

September 20, 2023 | 4:13 pm

CATC

FRTX

GIS

ICCM

SCS

SEEL

SPRY

U.S. stocks traded mixed with the Nasdaq Composite turning lower. General Mills Inc reported better-than-expected earnings for its first quarter. Steelcase Inc. reported better-than-expected results for its second quarter. Shares of Cambridge Bancorp surged after the company announced a merger with Eastern Bankshares. Fresh Tracks Therapeutics shares were up after the company announced a plan of liquidation and dissolution. Seelos Therapeutics shares dropped after its SLS-002 Phase II study did not meet the pre-defined primary endpoint. ARS Pharmaceuticals shares were down after the FDA issued a Complete Response Letter regarding its New Drug Application. IceCure Medical shares fell after the FDA denied its De Novo Classification request for breast cancer.

Portfolio Pulse from Lisa Levin

September 20, 2023 | 4:09 pm

EVAX

Evaxion Biotech has announced a collaboration with Afrigen Biologics to develop a mRNA vaccine against Gonorrhea. This news has led to a rise in Evaxion's stock prices.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 4:05 pm

VCEL

J Capital Research has released a short report on Vericel Corporation (NASDAQ:VCEL), a company specializing in cartilage-repair and burn treatment products. Despite promising applications, Vericel has consistently underperformed, with losses each year since 1996, except for a $2.9 million profit in 2020. The company's market capitalization has grown by 38% to $1.7 billion, coinciding with an increase in losses over the past three years. Vericel's management continues to award itself generous stock-based compensation packages, despite the company's financial struggles.

Portfolio Pulse from Vandana Singh

September 20, 2023 | 4:04 pm

SKIN

Beauty Health Co (NASDAQ:SKIN) plans to initiate a stock repurchase program on September 26, 2023, through Rule 10b5-1. The company's Board of Directors has authorized the repurchase of up to $100 million of its common stock. The company intends to fund its share repurchases with existing cash on hand and is not obligated to acquire any particular amount of stock. As of June 30, 2023, the company held $549.7 million in cash and equivalents.

Portfolio Pulse from Shivani Kumaresan

September 20, 2023 | 4:03 pm

NIO

NIO shares are experiencing volatility following the company's announcement of a proposed offering of $1 billion convertible senior notes.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 4:03 pm

MKUL

Molekule Group has announced that its board has authorized the management to commence preparation of a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 4:03 pm